These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 10341143

  • 1. A physiologically based pharmacokinetic model of inorganic arsenic.
    Yu D.
    Regul Toxicol Pharmacol; 1999 Apr; 29(2 Pt 1):128-41. PubMed ID: 10341143
    [Abstract] [Full Text] [Related]

  • 2. A pharmacokinetic modeling of inorganic arsenic: a short-term oral exposure model for humans.
    Yu D.
    Chemosphere; 1999 Dec; 39(15):2737-47. PubMed ID: 10633549
    [Abstract] [Full Text] [Related]

  • 3. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water.
    Kenyon EM, Hughes MF, Adair BM, Highfill JH, Crecelius EA, Clewell HJ, Yager JW.
    Toxicol Appl Pharmacol; 2008 Nov 01; 232(3):448-55. PubMed ID: 18706920
    [Abstract] [Full Text] [Related]

  • 4. A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans.
    Mann S, Droz PO, Vahter M.
    Toxicol Appl Pharmacol; 1996 Oct 01; 140(2):471-86. PubMed ID: 8887465
    [Abstract] [Full Text] [Related]

  • 5. Kinetics of arsenic methylation by freshly isolated B6C3F1 mouse hepatocytes.
    Kedderis GL, Elmore AR, Crecelius EA, Yager JW, Goldsworthy TL.
    Chem Biol Interact; 2006 Jun 10; 161(2):139-45. PubMed ID: 16725132
    [Abstract] [Full Text] [Related]

  • 6. Physiologically based pharmacokinetic modeling of arsenic in the mouse.
    Gentry PR, Covington TR, Mann S, Shipp AM, Yager JW, Clewell HJ.
    J Toxicol Environ Health A; 2004 Jan 09; 67(1):43-71. PubMed ID: 14668111
    [Abstract] [Full Text] [Related]

  • 7. A physiologically based pharmacokinetic model for arsenic exposure. I. Development in hamsters and rabbits.
    Mann S, Droz PO, Vahter M.
    Toxicol Appl Pharmacol; 1996 Mar 09; 137(1):8-22. PubMed ID: 8607145
    [Abstract] [Full Text] [Related]

  • 8. [Effect of glutathione and methionine on the distribution and methylic metabolism of arsenic speciation in mice exposed to arsenic through drinking water].
    Zhong Y, Yu X, Qu C, Niu Y.
    Wei Sheng Yan Jiu; 2008 Jul 09; 37(4):390-2, 396. PubMed ID: 18839517
    [Abstract] [Full Text] [Related]

  • 9. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells.
    Dopp E, Hartmann LM, Florea AM, von Recklinghausen U, Pieper R, Shokouhi B, Rettenmeier AW, Hirner AV, Obe G.
    Toxicol Appl Pharmacol; 2004 Dec 01; 201(2):156-65. PubMed ID: 15541755
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report.
    Clewell HJ, Thomas RS, Gentry PR, Crump KS, Kenyon EM, El-Masri HA, Yager JW.
    Toxicol Appl Pharmacol; 2007 Aug 01; 222(3):388-98. PubMed ID: 17499324
    [Abstract] [Full Text] [Related]

  • 13. Arsenic drinking water exposure and urinary excretion among adults in the Yaqui Valley, Sonora, Mexico.
    Meza MM, Kopplin MJ, Burgess JL, Gandolfi AJ.
    Environ Res; 2004 Oct 01; 96(2):119-26. PubMed ID: 15325872
    [Abstract] [Full Text] [Related]

  • 14. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan.
    Tseng CH, Huang YK, Huang YL, Chung CJ, Yang MH, Chen CJ, Hsueh YM.
    Toxicol Appl Pharmacol; 2005 Aug 15; 206(3):299-308. PubMed ID: 16039941
    [Abstract] [Full Text] [Related]

  • 15. Arsenic methylation capacity and skin cancer.
    Yu RC, Hsu KH, Chen CJ, Froines JR.
    Cancer Epidemiol Biomarkers Prev; 2000 Nov 15; 9(11):1259-62. PubMed ID: 11097236
    [Abstract] [Full Text] [Related]

  • 16. [Effect of glutathione and sodium selenite on the metabolism of arsenic in mice exposed to arsenic through drinking water].
    Yu XY, Zhong Y, Niu YH, Qu CQ, Li GX, Lü XQ, Sun GF, Jin YP.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Sep 15; 42(9):636-9. PubMed ID: 19175171
    [Abstract] [Full Text] [Related]

  • 17. Role of metabolism in arsenic toxicity.
    Vahter M, Concha G.
    Pharmacol Toxicol; 2001 Jul 15; 89(1):1-5. PubMed ID: 11484904
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of a Physiologically Based Pharmacokinetic (PBPK) Model for Inorganic Arsenic Exposure Using Data from Two Diverse Human Populations.
    El-Masri HA, Hong T, Henning C, Mendez W, Hudgens EE, Thomas DJ, Lee JS.
    Environ Health Perspect; 2018 Jul 15; 126(7):077004. PubMed ID: 30024383
    [Abstract] [Full Text] [Related]

  • 19. Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and di-methylated metabolites.
    El-Masri HA, Kenyon EM.
    J Pharmacokinet Pharmacodyn; 2008 Feb 15; 35(1):31-68. PubMed ID: 17943421
    [Abstract] [Full Text] [Related]

  • 20. Role of glutathione in reduction of arsenate and of gamma-glutamyltranspeptidase in disposition of arsenite in rats.
    Csanaky I, Gregus Z.
    Toxicology; 2005 Feb 01; 207(1):91-104. PubMed ID: 15590125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.